Paracoccidioidomycosis

Common Name(s)

Paracoccidioidomycosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Paracoccidioidomycosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Paracoccidioidomycosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Paracoccidioidomycosis" returned 209 free, full-text research articles on human participants. First 3 results:

Increased peripheral blood TCD4+ counts and serum SP-D levels in patients with chronic paracoccidioidomycosis, during and after antifungal therapy.
 

Author(s): James Venturini, Ricardo Souza Cavalcante, Tatiane Fernanda Sylvestre, Rodolfo Ferreira Dos Santos, Daniela Vanessa Moris, Lídia Raquel Carvalho, Maria Sueli Parreira de Arruda, Marjorie de Assis Golim, Rinaldo Poncio Mendes

Journal: Mem. Inst. Oswaldo Cruz. 2017 Nov;112(11):748-755.

 

The main clinical forms of paracoccidioidomycosis (PCM) are the acute/subacute form (AF) and the chronic form (CF), and they both display considerable clinical variability. The immune responses of PCM patients, during and after treatment, remain neglected, mainly in the case of CF ...

Last Updated: 31 Dec 1969

Go To URL
Hypereosinophilia Secondary to Disseminated Paracoccidioidomycosis.
 

Author(s): Mateo Mejia-Zuluaga, Samuel Rosas, Verónica Posada Vélez, Pedro A Quintero

Journal:

 

BACKGROUND Paracoccidioidomycosis is an endemic mycosis in Central and South America caused by the thermally dimorphic fungus Paracoccidioides brasiliensis. Despite its self-limited course and usually asymptomatic infection, some patients may present with a systemic illness mimicking ...

Last Updated: 31 Dec 1969

Go To URL
Case report of myeloperoxidase deficiency associated with disseminated paracoccidioidomycosis and peritoneal tuberculosis.
 

Author(s): Maurício Domingues-Ferreira, Ariel Levy, Noac Chuffi Barros, Dalton Luis Bertolini, Dewton de Moraes Vasconcelos

Journal: Rev. Soc. Bras. Med. Trop.. ;50(4):568-570.

 

Myeloperoxidase (MOP) is present in monocyte and neutrophil lysosomes, catalyzing hydrogen peroxide and chloride ion conversion to hypochlorous acid. MOP seems to destroy pathogens during phagocytosis by neutrophils and is considered an important defense against innumerous bacteria. ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Paracoccidioidomycosis" returned 16 free, full-text review articles on human participants. First 3 results:

Paracoccidioidomycosis in the spine: case report and review of the literature.
 

Author(s): José Alexandre Lopes da Silva Alvarenga, Délio Eulálio Martins, Michel Kanas, Hugo Gustavo Kunzle Elizeche, Adriana Macêdo Dell'Aquila, Eloy De Avila Fernandes, Marcelo Wajchenberg, Eduardo Barros Puertas

Journal: Sao Paulo Med J. ;134(3):263-267.

 

Paracoccidioidomycosis is a systemic form of mycosis that spreads hematogenously, secondarily to reactivation of lung infection or infection at another site or to new exposure to the causative agent. Few cases of bone involvement have been reported in the literature and involvement ...

Last Updated: 31 Dec 1969

Go To URL
PARACOCCIDIOIDOMYCOSIS TREATMENT.
 

Author(s): Maria Aparecida Shikanai-Yasuda

Journal: Rev. Inst. Med. Trop. Sao Paulo. 2015 Sep;57 Suppl 19():31-7.

 

Considered to be an emerging endemic mycosis in Latin America, paracoccidioidomycosis is characterized by a chronic course and involvement of multiple organs in immunocompromised hosts. Infection sequelae are mainly related to pulmonary and adrenal insufficiency. The host-parasite ...

Last Updated: 31 Dec 1969

Go To URL
PARACOCCIDIOIDOMYCOSIS: CHALLENGES IN THE DEVELOPMENT OF A VACCINE AGAINST AN ENDEMIC MYCOSIS IN THE AMERICAS.
 

Author(s): Carlos P Taborda, M E Urán, J D Nosanchuk, L R Travassos

Journal: Rev. Inst. Med. Trop. Sao Paulo. 2015 Sep;57 Suppl 19():21-4.

 

Paracoccidioidomycosis (PCM), caused by Paracoccidioides spp, is an important endemic mycosis in Latin America. There are two recognized Paracoccidioides species, P. brasiliensis and P. lutzii, based on phylogenetic differences; however, the pathogenesis and disease manifestations ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.